Devices are increasingly infiltrating clinical segments where once only drugs held sway, and nowhere more so than in neuromodulation. These implantable devices can therapeutically influence the activity of the body's nervous system, either electrically or pharmacologically, and they're reaching into conventional drug markets such as pain, depression, chronic migraines, and epilepsy.
According to "Opportunities in Global Medical Devices and Diagnostics," a report recently published by Health Research International (HRI) and distributed...